Rheumatology Book

//fpnotebook.com/

Antinuclear Antibody

Aka: Antinuclear Antibody, Anti-Nuclear Antibody Test, Antinuclear Antigen, ANA
  1. Causes: Negative
    1. Normal titer less than 1:20 dilution
    2. See interpretation below regarding titers
  2. Causes: Positive
    1. Normal patient without underlying abnormality: 3-30%
      1. More common in older women
    2. Rheumatologic Conditions
      1. Systemic Lupus Erythematosus
      2. Rheumatoid Arthritis
      3. Mixed Connective Tissue Disease
      4. Sjogren's Syndrome
      5. Necrotizing Vasculitis
    3. Infection
      1. Tuberculosis
      2. Chronic active hepatitis (e.g. Hepatitis C)
      3. Subacute Bacterial Endocarditis
      4. HIV Infection
    4. Miscellaneous Conditions
      1. Type I Diabetes Mellitus
      2. Hashimoto Thyroiditis
      3. Multiple Sclerosis
      4. Pulmonary fibrosis
      5. Silicone gel implants
      6. Pregnant women
      7. Elderly patients
    5. Medications (Drug Induced Lupus Erythematosus)
      1. Phenytoin
      2. Ethosuximide
      3. Primidone
      4. Methyldopa
      5. Hydralazine
      6. Penicillamine
      7. Carbamazepine
      8. Procainamide
      9. Thiazides
      10. Griseofulvin
      11. Chlorpromazine
      12. Isoniazid
      13. Quinidine
      14. Gold Salts
      15. Minocycline
  3. Mechanism
    1. IgG or IgM Antinuclear Antibody (ANA)
    2. Antibody binds to nuclei or nuclear components
  4. Precautions
    1. Almost all patients with Systemic Lupus Erythematosus (SLE) have a positive ANA titer
    2. Most patients with a positive ANA titer do not have Systemic Lupus Erythematosus (SLE)
      1. High False Positive Rate (esp. low titers) and in Autoimmune Conditions (see above)
    3. ANA Levels fluctuate and do not correlate with response to therapy or with disease activity
      1. Once ANA test is positive, repeat testing is rarely indicated
  5. Labs: Indirect Immunofluorescence Assay (IIF) Slide test
    1. Uses fixed and permeabilized human epithelial cells (HEp-2 cells)
    2. Labor intensive
    3. Most accurate ANA Test
      1. Test Sensitivity: 93%
      2. Test Specificity: 57%
      3. Positive Likelihood Ratio (LR+) for SLE: 2.2
      4. Negative Likelihood Ratio (LR-) for SLE: 0.1
    4. Measures direct binding
      1. Patient's serum antibodies to cell nuclei
      2. Specific components of cell nucleus are also bound
        1. See ANA subunits below
  6. Labs: Enzyme-Linked Immunosorbent Assay (ELISA)
    1. Less labor intensive and less costly than Indirect Immunofluorescence Assay (IIF) Slide Test
    2. Less accurate than Indirect Immunofluorescence Assay (IIF) Slide Test
      1. Test Sensitivity: 81.9%
      2. Test Specificity: 79.6%
      3. Positive Likelihood Ratio (LR+) for SLE: 2.97
      4. Negative Likelihood Ratio (LR-) for SLE: 0.25
  7. Interpretation: Titer (Dilution)
    1. Pretest probability affects interpretation
      1. Primary Care Setting: 2% SLE probability
      2. Rheumatology Setting: 30% SLE probability
    2. Low Positive (1:160 or lower): Low significance
      1. SLE Likelihood: <2% (<26% for rheumatologists)
    3. High Positive (1:320 or higher): Higher significance
      1. SLE Likelihood: 2-17% (32-81% for rheumatologists)
    4. References
      1. Malleson (1997) Arch Dis Child 77:299-304 [PubMed]
  8. Interpretation: ANA Staining Patterns
    1. Systemic Lupus Erythematosus specific patterns
      1. ANA Rim Pattern
      2. ANA Homogenous Pattern (ANA Diffuse Pattern)
    2. Sjogren Syndrome
      1. ANA Speckled Pattern
    3. Scleroderma Specific Patterns
      1. ANA Nucleolar Pattern
    4. CREST Syndrome Specific Patterns
      1. ANA Centromere Pattern
  9. Interpretation: ANA Subunits
    1. Systemic Lupus Erythematosus
      1. Anti-dsDNA (SLE Test Sensitivity: 60%)
        1. Specific for lupus erythematosus
        2. Associated with Lupus Nephritis
        3. Associated with Lupus CNS Involvement
      2. Anti-Smith or Anti-Sm (SLE Test Sensitivity: 20-30%)
        1. Highly specific for lupus erythematosus
      3. Anti-ribosomal P (SLE Test Sensitivity: 20-30%)
        1. Highly specific for lupus erythematosus
        2. Associated with Lupus Psychosis
      4. Anti-RNP (SLE Test Sensitivity: 30-40%)
        1. Associated with lupus disease activity
        2. Seen in all cases Mixed Connective Tissue Disease
      5. Anticardiolipin Antibody
      6. Lupus Anticoagulant
      7. Consider Sjogren Antibodies (Anti-SSA and Anti-SSB)
    2. CREST and Scleroderma
      1. Anti-centromere
        1. Sensitivity for Scleroderma: 22-36%
      2. Scl-70 kD kinetochore (Anti-Topoisomerase I)
        1. Sensitivity for Scleroderma: 22-40%
    3. Polymyositis and Dermatomyositis
      1. Anti-Jo1 (sensitivity: 30%)
        1. Also in Raynaud's Phenomenon, pulmonary fibrosis
      2. Anti-Ku
      3. Anti-Mi2
    4. Sjogren Syndrome
      1. Anti-Ro (Anti-SSA)
        1. Sjogren's SyndromeTest Sensitivity: 75%
        2. Systemic Lupus ErythematosusTest Sensitivity: 40%
      2. Anti-La (Anti-SSB)
        1. Sjogren's SyndromeTest Sensitivity: 40%
        2. Systemic Lupus ErythematosusTest Sensitivity: 10-15%
    5. Drug Induced Lupus
      1. Anti-histone
        1. Drug-induced LupusTest Sensitivity: 95%
        2. Drug-induced LupusTest Specificity: >90%
        3. Systemic Lupus ErythematosusTest Sensitivity: 50%
    6. Non-specific
      1. Anti-ssDNA
        1. Non-specific and rarely indicated
  10. References
    1. Gladman in Klippel (1997) Rheumatic Diseases p. 255-6
    2. Peng in Ruddy (2001) Kelley's Rheumatology, p. 161-72
    3. Ali (2018) Am Fam Physician 98(3): 164-70 [PubMed]
    4. Callegari (1995) Postgrad Med, 97(4):65-74 [PubMed]
    5. Lane (2002) Am Fam Physician 65(6):1073-80 [PubMed]

Antibodies, Antinuclear (C0003243)

Definition (NCI) An autoimmune antibody that is directed against structures within the nucleus of the cell.
Definition (MSH) Autoantibodies directed against various nuclear antigens including DNA, RNA, histones, acidic nuclear proteins, or complexes of these molecular elements. Antinuclear antibodies are found in systemic autoimmune diseases including systemic lupus erythematosus, Sjogren's syndrome, scleroderma, polymyositis, and mixed connective tissue disease.
Definition (CSP) autoimmune, pathological antibodies against histones, DNA, nuclear RNA, or other components of the cell nucleus.
Concepts Amino Acid, Peptide, or Protein (T116) , Immunologic Factor (T129)
MSH D000974
SnomedCT 165849001, 45530001
English Antibodies, Antinuclear, Antibody, Antinuclear, Antinuclear Antibodies, Antinuclear Antibody, Antinuclear Factor, Antinuclear Factors, Factor, Antinuclear, Factors, Antinuclear, antinuclear autoantibody, ANTINUCLEAR FACTOR, antinuclear antibody, antiDNA autoantibody, antinuclear factor, Antinuclear Autoantibody, Antibodies, Antinuclear [Chemical/Ingredient], antinuclear antibody (ANA), anti-nuclear antibody, antinuclear factors, antinuclear antibodies, antinuclear antibody ana, ana, Anti-nuclear factor, Anti nuclear factor, Antinuclear factors, ANF, ANA, ANA - Anti-nuclear antibody, ANF - Anti-nuclear factor, Anti-nuclear antibody, Antinuclear antibody, Antinuclear factor, Antinuclear antibody (substance)
Swedish Antinukleära antikroppar
Finnish Tumavasta-aineet
Italian Fattore antinucleare, Anticorpo antinucleare, Fattori antinucleari, Anticorpi antinucleari
Russian ANTINUKLEARNYE FAKTORY, ANTI-DNK ANTITELA, ANTITELA ANTI-DNK, ANTITELA ANTINUKLEARNYE, FLIUORESTSENTNYE ANTINUKLEARNYE ANTITELA, ANTINUKLEARNYE ANTITELA, АНТИ-ДНК АНТИТЕЛА, АНТИНУКЛЕАРНЫЕ АНТИТЕЛА, АНТИНУКЛЕАРНЫЕ ФАКТОРЫ, АНТИТЕЛА АНТИ-ДНК, АНТИТЕЛА АНТИНУКЛЕАРНЫЕ, ФЛЮОРЕСЦЕНТНЫЕ АНТИНУКЛЕАРНЫЕ АНТИТЕЛА
French ANTICORPS ANTINUCLEAIRES, Facteurs lupiques, Anticorps anti-nucléaires, Anticorps antinucléaires, Facteurs antinucléaires, Facteurs anti-nucléaires, Anticorps antinucléaire, Anticorps anti-nucléaire, ACAN, FAN (Facteur AntiNucléaire)
Portuguese FACTOR ANTINUCLEAR, Anticorpos Antinucleares, Fatores Antinucleares
Japanese 抗体-抗核, 抗DNA抗体, 抗核因子, 蛍光抗核抗体, 抗核抗体
Croatian ANTITIJELA, ANTINUKLEARNA
Polish Przeciwciała przeciwjądrowe, Czynniki przeciwjądrowe
Czech antinukleární protilátky, antinukleární faktory, protilátky antinukleární, antinukleární faktor
Spanish FAN, anticuerpo antinuclear (sustancia), anticuerpo antinuclear, factor antinuclear, Anticuerpos Antinucleares, Factores Antinucleares
German Antikörper, antinukleäre, Antinukleäre Antikörper, Antinukleäre Faktoren
Sources
Derived from the NIH UMLS (Unified Medical Language System)


Anti-nuclear antibody measurement (C0587178)

Definition (NCI_CDISC) A measurement of the antinuclear antibodies (antibodies that attack the body's own tissue) in a biological specimen.
Definition (NCI) The determination of the amount of antinuclear antibodies present in a sample.
Concepts Laboratory Procedure (T059)
SnomedCT 359788000, 390280009, 79404001, 269837009, 389548001
CPT 86038, 1014272
English ANA, Antinuclear antibodies (ANA), Antinuclear antibody, Antinuclear factor, ANA measurement (procedure), Antinuclear antibody (ANA) measurement, Nuclear antibody, Antinuclear Antibody Measurement, Test;anti nuclear antibodies, antinuclear antibody (ANA) test, anti nuclear antibodies test, anti antibody nuclear test, ANTINUCLEAR ANTIBODIES ANA, Antinuclear antibody measurement (procedure), Antinuclear antibody measurement, Antinuclear antibody (ANA) measurement (procedure), Measurement of antinuclear antibodies (ANA), Anti-nuclear factor level, Anti-nuclear antibody measurement (procedure), Anti-nuclear factor level (procedure), Antinuclear Antibodies, ANA - Anti-nuclear antibody level, Anti-nuclear antibody level, ANA measurement, Anti-nuclear antibody measurement, Anti-nuclear antibody measurement, NOS, ANA measurement, NOS, ANTINUCLEAR ANTIBODIES, Antinuclear antibodies, Anti-nuclear antibody measurement (procedure) [Ambiguous]
Italian Anticorpo antinucleo, Anticorpi antinucleo, Anticorpo nucleare, Fattore antinucleare
Spanish dosaje de anticuerpos antinucleares, dosaje de AAN, ANA, Factor antinuclear, medición de anticuerpos antinucleares, dosaje de anticuerpos antinucleares (procedimiento), medición de anticuerpos antinucleares (procedimiento), medición de AAN, medición de ANA, medición de anticuerpos anti - ácido desoxirribonucleico, medición de anticuerpos antinucleares (concepto no activo), Anticuerpos antinucleares
Dutch antinucleaire factor, ANA, nucleaire antistof, antinucleaire antistof
French Anticorps anti-nucléaire, Facteur antinucléaire, ANA, Anticorps anti-nucléaires
German nukleaerer Antikoerper, ANA, antinukleaerer Faktor, antinukleaerer Antikoerper
Portuguese ANA, Factor antinuclear, Anticorpo nuclear, Anticorpos antinucleares
Japanese 抗核抗体, 抗核因子, ANA, 核抗体, コウカクコウタイ, カクコウタイ, コウカクインシ, ANA
Czech Antinukleární protilátky, Nukleární protilátky, ANA, Antinukleární faktor
Hungarian Antinukleáris antitest, ANA, Antinukleáris faktor, Nukleáris antitest
Sources
Derived from the NIH UMLS (Unified Medical Language System)


You are currently viewing the original 'fpnotebook.com\legacy' version of this website. Internet Explorer 8.0 and older will automatically be redirected to this legacy version.

If you are using a modern web browser, you may instead navigate to the newer desktop version of fpnotebook. Another, mobile version is also available which should function on both newer and older web browsers.

Please Contact Me as you run across problems with any of these versions on the website.

Navigation Tree